4-(2,3-Bis-hydroxymethyl-6,7-dimethoxy-naphthalen-1-yl)-1-butyl-3,6-dihydro-1H-pyridin-2-one

ID: ALA2115234

PubChem CID: 10763354

Max Phase: Preclinical

Molecular Formula: C23H27NO5

Molecular Weight: 397.47

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCn1ccc(-c2c(CO)c(CO)cc3cc(OC)c(OC)cc23)cc1=O

Standard InChI:  InChI=1S/C23H27NO5/c1-4-5-7-24-8-6-15(11-22(24)27)23-18-12-21(29-3)20(28-2)10-16(18)9-17(13-25)19(23)14-26/h6,8-12,25-26H,4-5,7,13-14H2,1-3H3

Standard InChI Key:  GLQDANQNRADIEB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    7.5897   -4.6327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2980   -3.5003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0129   -3.9121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3780   -6.0454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2980   -2.6767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5716   -5.9253    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7335   -3.4889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5887   -3.9121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8927   -5.4048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7775   -4.5012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7335   -2.6824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0129   -2.2649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8681   -3.4889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5887   -2.2649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8681   -2.6824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2627   -5.1361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6697   -6.8176    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1474   -3.8949    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1361   -2.2878    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4599   -3.8949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9882   -6.5029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4713   -2.2878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4713   -4.7185    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4942   -1.4584    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4326   -2.7281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4440   -3.4717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1989   -6.2799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6041   -6.8519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8091   -6.6288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  1  1  0
  4  9  1  0
  5  2  1  0
  6 16  1  0
  7  3  2  0
  8  2  2  0
  9  1  2  0
 10  1  1  0
 11  7  1  0
 12 11  2  0
 13  8  1  0
 14  5  2  0
 15 13  2  0
 16 10  2  0
 17  4  2  0
 18 13  1  0
 19 15  1  0
 20  7  1  0
 21  6  1  0
 22 11  1  0
 23 20  1  0
 24 22  1  0
 25 19  1  0
 26 18  1  0
 27 21  1  0
 28 27  1  0
 29 28  1  0
  6  4  1  0
  5 12  1  0
 15 14  1  0
M  END

Associated Targets(Human)

PDE1A Tclin Phosphodiesterase 1 (671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3 (1749 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4A Tclin Phosphodiesterase 4 (3344 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4A Tclin Phosphodiesterase; PDE3 & PDE4 (301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cavia porcellus (23802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 397.47Molecular Weight (Monoisotopic): 397.1889AlogP: 3.47#Rotatable Bonds: 8
Polar Surface Area: 80.92Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.22CX LogD: 2.22
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.61Np Likeness Score: 0.05

References

1. Iwasaki T, Kondo K, Kuroda T, Moritani Y, Yamagata S, Sugiura M, Kikkawa H, Kaminuma O, Ikezawa K..  (1996)  Novel selective PDE IV inhibitors as antiasthmatic agents. Synthesis and biological activities of a series of 1-aryl-2,3-bis(hydroxymethyl)naphthalene lignans.,  39  (14): [PMID:8709099] [10.1021/jm9509096]
2. Iwasaki T, Kondo K, Kuroda T, Moritani Y, Yamagata S, Sugiura M, Kikkawa H, Kaminuma O, Ikezawa K..  (1996)  Novel selective PDE IV inhibitors as antiasthmatic agents. Synthesis and biological activities of a series of 1-aryl-2,3-bis(hydroxymethyl)naphthalene lignans.,  39  (14): [PMID:8709099] [10.1021/jm9509096]

Source